Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM1 | P23921 | 8/20 | 0.39 |
| ▸ | RRM2 | P31350 | 8/20 | 0.39 |
| ▸ | RRM2B | Q7LG56 | 8/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24964897 | 1.00 | RRM1 (0.39) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL24964930 | 0.88 | RRM1 (0.40) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL24964928 | 0.88 | RRM1 (0.40) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL24965156 | 0.87 | RRM1 (0.36) | RRM1RRM2RRM2B | |
| SCHEMBL24965154 | 0.87 | RRM1 (0.36) | RRM1RRM2RRM2B | |
| SCHEMBL24963368 | 0.85 | RRM1 (0.37) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL24963364 | 0.85 | RRM1 (0.37) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL24966031 | 0.84 | RRM1 (0.36) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL24966032 | 0.84 | RRM1 (0.36) | RRM1RRM2RRM2BITGB3ITGA2B | |
| SCHEMBL29709560 | 0.84 | MME (0.36) | RRM1RRM2RRM2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | DNPEP, VIP, NPEPPS | RRM1 3109/4885RRM2 3607/4885RRM2B 3680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.